17 results on '"Rodinò, C."'
Search Results
2. Evaluation of the Prognostic Role of Vascular Endothelial Growth Factor and Microvessel Density in Stages I and II Breast Cancer Patients
3. Cisplatin, epirubicin, leucovorin and 5-fluorouracil (PELF) is more active than 5-fluorouracil, doxorubicin and methotrexate (FAMTX) in advanced gastric carcinoma
4. Epirubicin versus CMF as adjuvant therapy for stage I and II breast cancer: a prospective randomised study
5. Use of ultrasound-guided thoracentesis to reduce iatrogenic risk of pneumothorax in patients with cancer.
6. Efficacy and safety of ultrasound-guided central venous access in oncological and haematological patients: Results of a monocenter series of 519 consecutive patients
7. Oncologic Emergencies Secondary to Advanced Colorectal Cancer Successfully Treated with Oxaliplatin/5-Fluorouracil/Leucovorin: Report of Three Cases
8. P86 Epirubicin as a single agent in comparison to CMF in adjuvant therapy of stage I and II breast cancer
9. 721 Hydroxyurea (HU), high dose folinic acid (L-FA) and 5FU VS HU, 5FU and interferon-alfa-2B (IFN) in advanced colorectal cancer (ACRC): A randomized trial of the italian oncology group for clinical research (GOIRC)
10. Fluorouracil, doxorubicin, and mitomycin combination versus PELF chemotherapy in advanced gastric cancer: a prospective randomized trial of the Italian Oncology Group for Clinical Research.
11. C-ERB-B2 expression as a predictor of outcome in a randomized trial comparing adjuvant CMF vs single-agent epirubicin in stage I-II breast cancer (BC) patients
12. 721 Hydroxyurea (HU), high dose folinic acid (L-FA) and 5FU VS HU, 5FU and interferon-alfa-2B(IFN) in advanced colorectal cancer (ACRC): A randomized trial of the italian oncology group for clinical research (GOIRC)
13. Ultrasound-guided central venous catheterization in cancer patients improves the success rate of cannulation and reduces mechanical complications: a prospective observational study of 1,978 consecutive catheterizations.
14. Oxaliplatin in combination with 5-fluorouracil (5-FU) and leucovorin (LV) in patients with metastatic gastric cancer (MGC).
15. Modulation of fluorouracil by methotrexate, leucovorin, and cisplatin (M-FLP) in the treatment of advanced pancreatic cancer: a phase II study of the Italian Oncology Group for Clinical Research (GOIRC).
16. The combination of cisplatin, doxorubicin, and mitomycin (PAM) compared with the FAM regimen in treating advanced gastric carcinoma. A phase II randomized trial of the Italian Oncology Group for Clinical Research.
17. Cisplatin and VP16 in metastatic breast carcinoma as a third-line chemotherapy: a randomized study comparing low versus high doses of cisplatin.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.